Recombinant Putative S-adenosyl-L-methionine-dependent methyltransferase MAP_3385 (MAP_3385)
Description
Introduction
Proteins are composed of amino acid chains, typically around 400 amino acids long, and the sequence of these amino acids determines the protein's three-dimensional shape, which dictates its function . Proteins interact and form attachments with various molecules and structures within organisms, and their shape determines their interactions, similar to how a key's shape determines the locks it can open .
Understanding Methyltransferases
Methyltransferases are enzymes that catalyze the transfer of a methyl group from a donor to an acceptor molecule. S-adenosyl-L-methionine (SAM) is a common methyl donor in these reactions .
MAP_3385 Overview
MAP_3385 is annotated as a recombinant putative S-adenosyl-L-methionine-dependent methyltransferase. This suggests it is a protein produced using recombinant DNA technology and is predicted to function as a methyltransferase, utilizing SAM as a cofactor.
Key Features of MAP_3385
-
Recombinant Production: Indicates the protein is produced through genetic engineering techniques, allowing for large-scale production and purification for research purposes.
-
Putative Function: The term "putative" suggests that the function is based on computational analysis and sequence homology but may not be experimentally verified.
-
S-adenosyl-L-methionine-dependent: Confirms that the enzyme utilizes SAM as a methyl donor, a common characteristic of methyltransferases .
-
Methyltransferase Activity: The protein is predicted to transfer a methyl group from SAM to another molecule, modifying the acceptor molecule's function or properties .
Potential Research Applications
-
Drug Discovery: Methyltransferases, like MAP_3385, can be targets for drug development. Inhibiting or modulating their activity can have therapeutic effects.
-
Enzyme Engineering: Understanding the structure and function allows for the engineering of the enzyme to have altered substrate specificity or improved catalytic activity.
-
Structural Biology: Studying the 3D structure of MAP_3385 can provide insights into the mechanism of methyl transfer and protein-cofactor interactions.
Tables
Product Specs
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Note: Our standard shipping includes blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
The specific tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Target Background
KEGG: mpa:MAP_3385
STRING: 262316.MAP3385
Q&A
Structural and Functional Characterization of MAP_3385
Q: What structural features distinguish MAP_3385 from other S-adenosylmethionine (SAM)-dependent methyltransferases?
MAP_3385 exhibits a conserved methyltransferase fold with a SAM-binding domain, but its substrate specificity and catalytic efficiency may differ due to unique residues in its active site. Structural studies (e.g., X-ray crystallography) are required to identify motifs that influence substrate binding or cofactor affinity .
Q: How can researchers validate the enzymatic activity of recombinant MAP_3385 in vitro?
Methods include:
-
Radiometric assays using [³H]-SAM to monitor methyl transfer.
-
LC-MS/MS to identify methylated products (e.g., proteins, lipids, or nucleic acids).
-
Kinetic analysis (Kₘ, Vₘₐₓ) to determine substrate preferences and catalytic efficiency .
Experimental Design for Functional Studies
Q: How should one design experiments to resolve conflicting reports on MAP_3385’s substrate specificity?
A tiered approach is recommended:
-
Bioinformatics analysis: Predict substrates via sequence homology (e.g., RGG motifs in RNA-binding proteins) or structural docking.
-
In vitro assays: Test purified recombinant MAP_3385 with candidate substrates under controlled conditions (pH, temperature, SAM concentration).
-
In vivo validation: Use CRISPR-edited knockout models or RNAi in Mycobacterium avium to correlate methylation patterns with MAP_3385 activity .
Q: What controls are essential for methyltransferase activity assays?
-
Negative controls: Reactions without SAM or with heat-inactivated enzyme.
-
Positive controls: Reactions with known methyltransferase-substrate pairs (e.g., TbPRMT1 and RBP16) .
Data Interpretation and Contradiction Resolution
Q: How to address discrepancies in methylation patterns observed in different Mycobacterium strains?
-
Genomic analysis: Compare MAP_3385 orthologs across strains for polymorphisms affecting catalytic activity.
-
Proteomic profiling: Use LC-MS/MS to map methylated residues in recombinant proteins or cell lysates.
-
Environmental modulation: Test enzyme activity under varying conditions (e.g., pH, redox states) to mimic in vivo environments .
Q: What bioinformatics tools are suitable for predicting MAP_3385’s methylation targets?
| Tool | Application | Limitation |
|---|---|---|
| Phyre2 | Structural prediction of active-site residues. | Limited to conserved domains. |
| PSIPRED | Secondary structure prediction for flexible regions. | Requires high-quality input sequences. |
| Docking (AutoDock) | SAM-binding domain modeling. | Depends on accurate ligand-receptor parameters. |
Advanced Methodologies for Mechanistic Studies
Q: How can researchers investigate MAP_3385’s role in phase separation or biomolecular condensates?
-
Fluorescence assays: Use fluorescently labeled substrates (e.g., GFP-tagged proteins) to monitor liquid-liquid phase separation (LLPS) in vitro.
-
Cryo-EM: Capture structural rearrangements in MAP_3385-methylated complexes.
-
Live-cell imaging: Track enzyme localization and condensate dynamics in M. avium .
Q: What strategies optimize inhibitor discovery for MAP_3385?
-
High-throughput screening: Test SAM analogs or small-molecule libraries for competitive inhibition.
-
Co-crystallization: Solve structures of MAP_3385 bound to inhibitors to guide rational drug design.
-
Enzymatic assays: Use fluorescent SAM derivatives (e.g., S-adenosyl-L-homocysteine) to monitor inhibition kinetics .
Cross-Species Comparative Analysis
Q: How does MAP_3385 compare to other mycobacterial methyltransferases?
| Feature | MAP_3385 (M. avium) | Homologs in M. tuberculosis |
|---|---|---|
| Domain structure | SAM-binding motif + catalytic domain. | Similar, but divergent N-terminal regions. |
| Substrate preference | Hypothetical; requires validation. | Known for lipid or protein methylation (e.g., Rv1266c). |
| Pathogenicity link | Unstudied; potential role in virulence. | Established roles in stress response or host interaction. |
Q: What evolutionary insights can be gained from MAP_3385’s phylogenetic tree?
-
Ortholog clustering: Identify conserved residues critical for catalysis.
-
Horizontal gene transfer analysis: Determine if MAP_3385 acquired unique features from other genera.
-
Functional divergence: Compare activity profiles with Escherichia coli or Bacillus subtilis homologs .
Challenges and Future Research Directions
Q: What technical hurdles limit MAP_3385’s functional characterization?
-
Low solubility: Recombinant expression may require solubility tags (e.g., MBP, GST).
-
Substrate ambiguity: Lack of validated physiological targets necessitates high-throughput screening.
-
Cofactor dependency: SAM availability in M. avium may influence in vivo activity.
Q: How can researchers leverage CRISPR-Cas9 for studying MAP_3385’s cellular role?
-
Gene deletion: Create Δmap_3385 mutants and screen for phenotypes (e.g., virulence attenuation).
-
Epitope tagging: Track subcellular localization (e.g., membrane vs. cytoplasmic).
-
Complementation: Rescue mutants with wild-type or catalytically inactive MAP_3385 to confirm enzymatic necessity .
Methodological Standards for Publication
Q: What experimental replicates and controls are required for publishing MAP_3385 studies?
-
Technical replicates: ≥3 independent assays per condition.
-
Biological replicates: ≥2 independent cultures or clones.
-
Statistical analysis: ANOVA or t-tests with p-values <0.05.
-
Negative controls: SAM-free reactions or unrelated methyltransferase assays.
